Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia

Seminars in Reproductive Endocrinology

Volumn 16, Issue 1, 1998, Pages 93-104

  Walsh, Scott W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Cytokines; Leukocytes; Lipid peroxides; Placenta; Preeclampsia

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; LIPID PEROXIDE; PROSTAGLANDIN; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE RELEASE; HUMAN; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW;

EID: 0031799998     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016256     Document Type: Review

References (122)

1. Chesley LC. Hypertensive disorders in pregnancy. New York: Appleton-Century-Crofts, 1978
2. Walsh SW. Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985;152:335-340
3. Friedman SA. Preeclampsia: A review of the role of prostaglandins. Obstet Gynecol 1988;71:122-137
4. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rodgers GM, McLaughlin MK. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol 1989;161:1025-1034
5. Walsh SW. Lipid peroxidation in pregnancy. Hypertens Pregnancy 1994;13:1-32
6. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: A prospective multicenter study. Am J Obstet Gynecol 1995;172:642-648
7. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-241
8. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications. Am J Obstet Gynecol 1996;175:1365-1370
9. Lorentzen B, Endresen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 1994;13:103-109
10. Gratacos E, Casals E, Sanllehy C, Cararach V, Alonso PL, Fortuny A. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 1996;75:896-901
11. Paolisso G, Gambardella A, Tagliamonte MR, et al. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? J Clin Endocrinol Metab 1996;81:4244-4248
12. Tabacova S, Little RE, Balabaeva L, Pavlova S, Petrov I. Complications of pregnancy in relation to maternal lipid peroxides, glutathione, and exposure to metals. Reprod Toxicol 1994;8:217-224
13. Luecken LJ, Suarez EC, Kuhn CM, et al. Stress in employed women: Impact of marital status and children at home on neurohormone output and home strain. Psychosom Med 1997;59:352-359
14. Torbergsen T, Oian P, Mathiesen E, Borud O. Pre-eclampsia - a mitochondrial disease? Acta Obstet Gynecol Scand 1989;68:145-148
15. Berkowitz K, Monteagudo A, Marks F, Jackson U, Baxi L. Mitochondrial myopathy and preeclampsia associated with pregnancy. Am J Obstet Gynecol 1990;162:146-147
16. Fridovich I. Hypoxia and oxygen toxicity. Adv Neurol 1979;26:255-259
17. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III. Williams obstetrics. Norwalk: Appleton & Lange, 1993:763-817
18. MacLennan AH. Multiple gestation. Clinical characteristics and management. In: Creasy RK, Resnik R (eds). Maternal-fetal medicine: Principles and practice. Philadelphia: W.B. Saunders, 1989:580-591
19. Ishihara M. Studies on lipoperoxide of normal pregnant women and of patients with toxemia of pregnancy. Clin Chim Acta 1978;84:1-9
20. Wickens D, Wilkins MH, Lunec J, Ball G, Dormandy TL. Free-radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem 1981;18:158-162
21. Wang Y, Walsh SW, Guo J, Zhang J. Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol 1991;165:1690-1694
22. Wisdom SJ, Wilson R, McKillop JH, Walker JJ. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol 1991;165:1701-1704
23. Cranfield IM, Gollan JL, White AG, Dormandy TL. Serum antioxidant activity in normal and abnormal subjects. Ann Clin Biochem 1979;16:299-306
24. Davidge ST, Hubel CA, Brayden RD, Capeless EC, McLaughlin MK. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 1992;79:897-901
25. Hubel CA, Kozlov AV, Kagan VE, et al. Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: Implications for oxidative stress. Am J Obstet Gynecol 1996;175:692-700
26. Sekiba K, Yoshioka T. Changes of lipid peroxidation and superoxide dismutase activity in the human placenta. Am J Obstet Gynecol 1979;135:368-371
27. Takehara Y, Yoshioka T, Sasaki J. Changes in the levels of lipoperoxide and antioxidant factors in human placenta during gestation. Acta Med Okayama 1990;44:103-111
28. Entman SS, Richardson LD. Clinical applications of the altered iron kinetics of toxemia of pregnancy. Am J Obstet Gynecol 1983;146:568-574
29. Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content of serum lipopro-tein fractions of pregnant subjects with or without pre-eclampsia. Clin Chim Acta 1981;115:155-161
30. Wang Y, Walsh SW, Guo J, Zhang J. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991;165:1695-1700
31. Uotila JT, Tuimala RJ, Aarnio TM, Pyykko KA, Ahotupa MO. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br J Obstet Gynaecol 1993;100:270-276
32. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum . Am J Obstet Gynecol 1996;174:975-982
33. Jain SK, Wise R. Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in preeclampsia. Mol Cell Biochem 1995;151:33-38
34. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85:353-356
35. Samuels P, Main EK, Mennuti MT, Gabbe SG. The origin of increased serum iron in pregnancy-induced hypertension. Am J Obstet Gynecol 1987;157:721-725
36. Entman SS, Kambam JR, Bradley CA, Cousar JB. Increased levels of carboxyhemoglobin and serum iron as an indicator of increased red cell turnover in preeclampsia. Am J Obstet Gynecol 1987;156:1169-1173
37. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 1990;186:1-85
38. Mikhail MS, Anyaegbunam A, Garfinkel D, Palan PR, Basu J, Romney SL. Preeclampsia and antioxidant nutrients: Decreased plasma levels of reduced ascorbic acid, αtocopherol, and beta-carotene in women with preeclampsia. Am J Obstet Gynecol 1994;171:150-157
39. Hubel CA, Kagan VE, Kisin ER, McLaughlin MK, Roberts JM. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: Implications for oxidative stress. Free Radic Biol Med 1997;23:597-609
40. Chen G, Wilson R, Boyd P, et al. Normal superoxide dismutase (SOD) gene in pregnancy-induced hypertension: Is the decreased SOD activity a secondary phenomenon? Free Radic Res 1994;21:59-66
41. Liochev SI, Fridovich I. How does superoxide dismutase protect against tumor necrosis factor: A hypothesis informed by effect of superoxide on "free" iron. Free Radic Biol Med 1997;23:668-671
42. Sutherland MW, Gebicki JM. A reaction between superoxide free radical and lipid hydroperoxide in sodium linoleate micelles. Arch Biochem Biophys 1982;214:1-11
43. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481-487
44. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 1990;87:1620-1624
45. Morrow JD, Roberts LJ II. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996;51:1-9
46. Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Invest 1996;3:179-184
47. Barden A, Beilin LJ, Ritchie J, Croft KD, Walters BN, Michael CA. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci Colch 1996;91:711-718
48. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci 1990;87:9383-9387
49. Roberts LJ II, Morrow JD. The isoprostanes: Novel markers of lipid peroxidation and potential mediators of oxidant injury. In: Samuelsson B, Ramwell PW, Paoletti R, et al. (eds). Advances in prostaglandin, thromboxane, and leukotriene research. Vol. 23. New York: Raven Press, 1995:219-224
50. Hoffman SW, Moore S, Ellis EF. Isoprostanes: Free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke 1997;28:844-849
51. 2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 1992;44:155-163
52. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993;264:C1619-C1624
53. 2-isoprostane, on endothelin release. Cardiovasc Pharmacol 1995;26(Suppl 3):S51-S52
54. Taylor RN, Varma M, Teng NNH, Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990;71:1675-1677
55. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 1991;165:724-727
56. Greer IA, Haddad NG, Dawes J, Johnstone FD, Calder AA. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989;96:978-982
57. Haeger M, Unander M, Norder-Hansson B, Tylman M, Bengtsson A. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 1992;79:19-26
58. Tsukimori K, Maeda H, Ishida K, Nagata H, Koyanagi T, Nakano H. The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet Gynecol 1993;81:536-540
59. Studena K, Sacks GP, Sargent IL, Redman CWG. Leucocyte phenotypic and functional changes in preeclampsia and normal pregnancy - combined detection by whole blood cytometry. (Abstract 664). J Soc Gynecol Invest 1997;4:247A
60. Barden A, Graham D, Beilin LJ, et al. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin Sci Colch 1997;92:37-44
61. Edwards SW. Biochemistry and physiology of the neutrophil. New York: Cambridge University Press, 1994
62. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol 1995;102:20-25
63. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994;170:1752-1759
64. 2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1. Prostaglandins 1986;32:111-115
65. 2 in mononuclear cells from preeclamptic women. Am J Obstet Gynecol 1993;169:1106-1111
66. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci 1985;82:8667-8671
67. Richter J, Gullberg U, Lantz M. TNF-induced superoxide anion production in adherent human neutrophils involves both the p55 and p75 TNF receptor. J Immunol 1995;154:4142-4149
68. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JCP. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: Does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol 1994;101:485-487
69. Toborek M, Barger SW, Mattson MP, Barve S, McClain CJ, Hennig B. Linoleic acid and TNF-α cross-amplify oxidative injury and dysfunction of endothelial cells. J Lipid Res 1996;37:123-135
70. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-1204
71. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981;81:22-29
72. Ogburn PL, Rejeshwari M, Turner SI, Hoegsberg B, Haning RV. Lipid and glucose metabolism in human placental culture. Am J Obstet Gynecol 1988;159:629-635
73. Walsh SW, Wang Y. Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 1993;169:1462-1466
74. Van Hien P, Kovacs K, Matkovics B. Properties of enzymes. I. Study of superoxide dismutase activity change in human placenta of different ages. Enzyme 1974;18:341-347
75. Guthenberg C, Mannervik B. Glutathione S-transferase (transferase p) from human placenta is identical or closely related to glutathione S-transferase (transferase p) from erythrocytes. Biochim Biophys Acta 1981;661:255-260
76. Di Ilio C, Polidoro G, Arduini A, Muccini A, Federici G. Glutathione peroxidase, glutathione reductase, glutathione S-transferase, and gamma-glutamyltranspeptidase activities in the human early pregnancy placenta. Biochem Med 1983;29:143-148
77. Jendryczko A, Drozdz M, Wojcik A. Regional variations in the activities of antioxidant enzymes in the term human placenta. Zentralbl Gynakol 1991;113:1059-1066
78. Poranen A-K, Ekblad U, Uotila P, Ahotupa M. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta 1996;17:401-405
79. Walsh SW, Wang Y. Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 1993;169:1456-1461
80. Watson AL, Palmer ME, Jauniaux E, Burton GJ. Variations in expression of copper/zinc superoxide dismutase in villous trophoblast of the human placenta with gestational age. Placenta 1997;18:295-299
81. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049-6055
82. Salo DC, Pacifici RE, Lin SW, Giulivi C, Davies KJA. Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J Biol Chem 1990;265:11919-11927
83. Harris ED. Copper as a cofactor and regulator of copper, zinc superoxide dismutase. J Nutr 1992;122:636-640
84. Lee MH, Park J-W. Lipid peroxidation products mediate damage of superoxide dismutase. Biochem Mol Biol Int 1995;35:1093-1102
85. Wang Y, Walsh SW, Kay HH. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 1992;167:946-949
86. Walsh SW, Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 1995;80:1888-1893
87. Walsh SW, Wang Y, Jesse R. Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. Hypertens Pregnancy 1996;15:101-111
88. Cester N, Staffolani R, Rabini RA, et al. Pregnancy induced hypertension: A role for peroxidation in microvillus plasma membranes. Mol Cell Biochem 1994;131:151-155
89. Walsh SW, Wang Y, Vaughan JE. Placental production of 8-isoprostane is significantly increased in preeclampsia. J Soc Gynecol Invest 1997;4:96A(Abstract 068)
90. Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 1996;28:488-493
91. Wang Y, Walsh SW. Increased mitochondrial lipid peroxidation in preeclamptic placentas can be explained by an increased amount of mitochondria (Abstract P188). J Soc Gynecol Invest 1995;2:310
92. Jones CJP, Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1980;1:61-76
93. Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol 1989;161:735-741
94. Malis CD, Bonventre JV. Mechanism of calcium potentiation of oxygen free radical injury to renal mitochondria. A model for post-ischemic and toxic mitochondrial damage. J Biol Chem 1986;261:14201-14208
95. 2+ homeostasis, cell death, proliferation, and differentiation. Chem Biol Interact 1991;77:1-23
96. Guyton AC. Textbook of medical physiology. Philadelphia: W.B. Saunders, 1991:14
97. Shanklin DR, Sibai BM. Ultrastructural aspects of pre-eclampsia II. Mitochondrial changes. Am J Obstet Gynecol 1990;163:943-953
98. Wang Y, Walsh SW. TNFα concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996;32:157-169
99. Wong GHW, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989;58:923-931
100. Radeke HH, Meier B, Topley N, Floge J, Habermehl GG, Resch K. Interleukin 1-α and tumor necrosis factor-α induce oxygen radical production in mesangial cells. Kidney Int 1990;37:767-775
101. Yamauchi N, Kuriyama H, Watanabe N, Neda H, Maeda M, Niitsu Y. Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res 1989;49:1671-1675
102. Matthews N, Neale ML, Jackson SK, Stark JM. Tumour cell killing by tumour necrosis factor: Inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology 1987;62:153-155
103. Zimmerman RJ, Chan A, Leadon SA. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res 1989;49:1644-1648
104. Schulze Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992;267:5317-5323
105. Kauma SW, Wang Y, Walsh SW. Preeclampsia is associated with decreased placental interleukin-6 production. J Soc Gynecol Invest 1995;2:614-617
106. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78
107. Vilcek J, Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991;266:7313-7316
108. Ala Y, Palluy O, Favero J, Bonne C, Modat G, Dornand J. Hypoxia/reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 production. Effects of free radical scavengers. Agents Actions 1992;37:134-139
109. Billiar RB, Pepe GJ, Albrecht ED. Immunocytochemical identification of the oestrogen receptor in the nuclei of cultured human placental syncytiotrophoblasts. Placenta 1997;18:365-370
110. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 1995;15:4971-4979
111. Winyard PG, Blake DR. Antioxidants, redox-regulated transcription factors, and inflammation. Adv Pharmacol 1997;38:403-421
112. Gorog P. Activation of human blood monocytes by oxidized polyunsaturated fatty acids: A possible mechanism for the generation of lipid peroxides in the circulation. Int J Exp Pathol 1991;72:227-237
113. Jaattela M, Kuusela P, Saksela E. Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues. Lab Invest 1988;58:48-52
114. Vince G, Shorter S, Starkey P, et al. Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin Exp Immunol 1992;88:174-180
115. Kulmacz RJ, Lands WEM. Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase. Prostaglandins 1983;25:531-540
116. Walsh SW, Wang Y, Jesse R. Peroxide induces vasocon-striction in the human placenta by stimulating thromboxane. Am J Obstet Gynecol 1993;169:1007-1012
117. Warso MA, Lands WEM. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull 1983;39:277-280
118. Wang J, Zhen E, Guo Z, Lu Y. Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: Protective effect of antioxidants. Free Radic Biol Med 1989;7:243-249
119. Galle J, Bassenge E, Busse R. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res 1990;66:1287-1293
120. Shatos MA, Doherty JM, Hoak JC. Alterations in human vascular endothelial cell function by oxygen free radicals: Platelet adherence and prostacyclin release. Arteriosclerosis Thromb 1991;11:594-601
121. Barrowcliffe TW, Gray E, Kerry PJ, Gutteridge JMC. Triglyceride-rich lipoproteins are responsible for thrombin generation induced by lipid peroxides. Thromb Haemostas 1984;52:7-10
122. Sibai BM, Anderson GD. Hypertension. In: Gabbe SG, Niebyl JR, Simpson JL (eds). Obstetrics. Normal and problem pregnancies. New York: Churchill Livingstone, 1991:993-1055